This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Engelhardt M, Bertz H, Afting M et al. High- versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34+ immunoselection J Clin Oncol 1999 17: 2160 2172
Demirer T, Ayui M, Ozcan M et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF Br J Haematol 2002 116: 468 474
Halle P, Kanold J, Rapatel C et al. Granulocyte colony-stimulating factor alone at 20 μg/kg vs 10 μg/kg for peripheral blood stem cell mobilization in children Pediatr Transplant 2000 4: 285 288
Kröger N, Renges H, Krüger W et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation Br J Haematol 2000 111: 761 765
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pérez-Dueñas, B., Alcorta, I., Estella, J. et al. Safety and efficacy of high-dose G-CSF (24 μg/kg) alone for PBSC moblization in children. Bone Marrow Transplant 30, 987–988 (2002). https://doi.org/10.1038/sj.bmt.1703723
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703723